tiprankstipranks
Advertisement
Advertisement
Prime Medicine reports Q1 EPS (28c), consensus (25c)
PremiumThe FlyPrime Medicine reports Q1 EPS (28c), consensus (25c)
2M ago
Prime Medicine management to meet with Oppenheimer
Premium
The Fly
Prime Medicine management to meet with Oppenheimer
2M ago
Prime Medicine Appoints Svetlana Makhni as New CFO
Premium
Company Announcements
Prime Medicine Appoints Svetlana Makhni as New CFO
3M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
4M ago
Prime Medicine Reports 2025 Results, Advances Gene Editing Pipeline
Premium
Company Announcements
Prime Medicine Reports 2025 Results, Advances Gene Editing Pipeline
4M ago
Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year
Premium
The Fly
Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year
4M ago
Prime Medicine initiated with an Outperform at LifeSci Capital
PremiumThe FlyPrime Medicine initiated with an Outperform at LifeSci Capital
6M ago
Prime Medicine: Buy Rating on Prime Editing Platform Targeting High-Value Liver and Lung Genetic Diseases, Led by PM577 in Wilson’s Disease
Premium
Ratings
Prime Medicine: Buy Rating on Prime Editing Platform Targeting High-Value Liver and Lung Genetic Diseases, Led by PM577 in Wilson’s Disease
6M ago
Prime Medicine announces NEJM publication of PM359 data
Premium
The Fly
Prime Medicine announces NEJM publication of PM359 data
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100